Stocks
ResMed (RMD) EBITDA margin US GAAP (year values) |
|||||||||
| 2022 | 2023 | 2023 | 2024 | 2024 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 32.9% | 31.7% | 32.2% | 36.1% | 34.2% | 36.0% | ||
| Changes by years, y/y, % | -1pp | +0pp | +4pp | -2pp | +1.1% | ||||
ResMed. EBITDA margin, %
ResMed. EBITDA margin, changes, pp
ResMed (RMD) EBITDA margin US GAAP (quarter values) |
||||||||
| 2024Q3 | 2024Q3 | 2024Q4 | 2024Q4 | 2025Q1 | LTM ? | |||
| EBITDA margin, % | ? | 31.3% | 35.9% | 37.5% | 34.5% | 36.0% | 36.0% | |
| Changes by years, y/y, % | +0pp | +5pp | +8pp | +5pp | +0pp | |||
| Changes by quarters, q/q, % | -2pp | +5pp | +2pp | -3pp | +2pp | |||
